Capital Raises
Dren Bio Raises $350 Million to Bring Blood Cancer Drug to Market
Dren Bio Inc., a privately held developer of antibody drugs, raised $350 million in an oversubscribed financing to carry its lead blood cancer treatment…
Archive
National Deal News from the HERE CITY Network
Archive
Dren Bio Inc., a privately held developer of antibody drugs, raised $350 million in an oversubscribed financing to carry its lead blood cancer treatment…